Elevance Health Inc (ELV)
456.69
+10.39
(+2.33%)
USD |
NYSE |
Mar 24, 16:00
456.85
+0.16
(+0.04%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 108.44B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -2.54% |
| Valuation | |
| PE Ratio | 18.42 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.7082 |
| Price to Book Value | 2.987 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.48 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6642 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 44.14% |
News
Headline
Wire
Time (ET)
MT Newswires
03/24 12:49
MT Newswires
03/21 09:45
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 04/20/2023* | -- | Results | Q1 2023 | -- | 9.34 | -- | |
| 04/20/2023* | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 01/25/2023 | -- | Results | Q4 2022 | 5.23 | 5.19 | 0.76% | |
| 01/25/2023 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 10/19/2022 | -- | Results | Q3 2022 | 7.53 | 7.15 | 5.28% | |
| 10/19/2022 | 08:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/20/2022 | 08:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/20/2022 | -- | Results | Q2 2022 | 8.04 | 7.74 | 3.84% |
*Estimated Date/Time
Earnings
Profile
Edit
| Elevance Health (formerly known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 47 million medical members as of September 2022. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid, too. |
| URL | https://www.elevancehealth.com |
| Investor Relations URL | https://ir.elevancehealth.com/ |
| HQ State/Province | Indiana |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 20, 2023 (est.) |
| Last Earnings Release | Jan. 25, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 09, 2023 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 5.12 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.841 |
| Yield to Sector | 0.5609 |
| Yield to Industry | 0.9841 |
| Last Dividend Amt. | 1.48 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Mar. 09, 2023 |
| Yield (TTM) | 1.16% |
| Forward Yield | 1.30% |
| Payout Ratio | 20.40% |
| Cash Payout Ratio | 16.96% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 24, 2023.
Fundamentals
| Revenue (TTM) | 156.60B |
| Total Expenses (TTM) | 148.83B |
| Net Income (TTM) | 6.025B |
| Total Assets (Quarterly) | 102.77B |
| Total Liabilities (Quarterly) | 66.38B |
| Shareholders Equity (Quarterly) | 36.31B |
| Cash from Operations (TTM) | 8.399B |
| Cash from Investing (TTM) | -4.56B |
| Cash from Financing (TTM) | -1.318B |
Ratings
Profile
Edit
| Elevance Health (formerly known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 47 million medical members as of September 2022. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid, too. |
| URL | https://www.elevancehealth.com |
| Investor Relations URL | https://ir.elevancehealth.com/ |
| HQ State/Province | Indiana |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 20, 2023 (est.) |
| Last Earnings Release | Jan. 25, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 09, 2023 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| IHF | 165.65M USD | 13.99% |
| PAVLX | 1.055B USD | 3.81% |
| FLPKX | 864.39M USD | 3.11% |
| VGHCX | 1.280B USD | 2.70% |
| DFUV | 181.35M USD | 2.29% |
| XLV | 863.22M USD | 2.27% |
| VHT | 391.54M USD | 2.03% |
| MTUM | 145.48M USD | 1.50% |
| VWNFX | 680.81M USD | 1.29% |
| FRGLX | 590.86M USD | 1.27% |
| VWELX | 1.214B USD | 1.15% |
| SCHG | 101.27M USD | 0.64% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ELV Tweets |